跳至主要内容
临床试验/NCT00703742
NCT00703742已完成不适用

A Neuroimaging and Epigenetic Investigation of Antidepressants in Depression

Kunming Medical University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2008年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200
试验地点
1
主要终点
change of fMRI after medication

研究概览

简要总结

The purpose of this study is:

  1. to find out the structural or functional effects of selective serotonin reuptake inhibitors (SSRI) in major depressive disorder (MDD);
  2. find special abnormalities in depression secondary to other disease, e.g., autoimmune disease like systemic lupus erythematosus (SLE).
  3. find the relationship between the efficacy of antidepressant and the change of neuroimaging in MDD
  4. to find possible predispose to MDD
  5. to explore the DNA methylation status in depression;

详细描述

  1. to explore the pathology of depression
  2. to identify the difference between MDD and depression secondary to other disease ,especially autoimmune disease
  3. to explore the effect of gene-environment interaction on the epigenetic regulation of the depression

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • DSM-IV Major Depression or Dysthymia
  • Age 18-65
  • Physically healthy
  • Drug-free

排除标准

  • Body metal (e.g., wire stitches, screws in bones, stainless steel hips)
  • History of Psychosis or Epilepsy
  • Current (past six months) Substance Use Disorder (illicit drugs and/or alcohol)
  • Bipolar I
  • Need for wash-out from effective treatment in order to participate
  • High suicide risk
  • Currently taking (within 2 weeks; 4 weeks for Fluoxetine) antidepressants

研究组 & 干预措施

A,1

Experimental

A: Escitalopram, 20 mg/day,8weeks

干预措施: Escitalopram (Drug)

结局指标

主要结局

change of fMRI after medication

时间窗: baseline, 4 weeks, 8 weeks

次要结局

未报告次要终点

研究者

发起方
Kunming Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yuqi Cheng

Vise director, psychiatry department, Kunming Medical University

Kunming Medical University

研究点 (1)

Loading locations...

相似试验